Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2024 ∙ Li, C. Li, P. Peddibhotla, B. Teng, C. Shi, A. Lu, X. Cai, P. Dai, Q. Wang, B.
Takotsubo syndrome and vaccines: a systematic review
Adolescents Adults Older adults COVID-19 Influenza Safety
Rating:
Critically low
2024 ∙ Dudeja, N. Khan, T. Varughese, D. T. Abraham, S. G. Ninan, M. M. Prasad, C. L. Sarkar, R. Kang, G.
Technologies for strengthening immunization coverage in India: a systematic review
South-East Asia India All age groups Coverage
Rating:
Not applicable
2024 ∙ Mirzakhani, M. Bayat, M. Dashti, M. Tahmasebi, S. Rostamtabar, M. Esmaeili Gouvarchin Ghaleh, H. Amani, J.
The Assessment of Anti-SARS-CoV-2 Antibodies in Different Vaccine Platforms: A Systematic Review and Meta-Analysis of COVID-19 Vaccine Clinical Trial Studies
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2024 ∙ Liu, R. Fan, Y. Patel, A. Liu, H. Du, X. Liu, B. Di Tanna, G. L.
The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis
Adults Older adults Influenza Efficacy/effectiveness Safety
Rating:
High
2024 ∙ Horn, E. K. Herrera-Restrepo, O. Acosta, A. M. Simon, A. Jackson, B. Lucas, E.
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies
Americas United States of America Adults Older adults Hepatitis A Economic aspects
Rating:
Not applicable
2024 ∙ Abu Serhan, H. Abu Suilik, H. Hassan, A. K. AlSamhori, J. F. Hassan, A. R. Siddiq, A. Ahmed, N. Elnahry, A. G.
The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review
Adults COVID-19 Safety
Rating:
Low
2024 ∙ Setiawan, D. Nurulita, N. A. Khoirunnisa, S. M. Postma, M. J.
The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women
All age groups Human papillomavirus (HPV) Efficacy/effectiveness Administration
Rating:
Critically low
2024 ∙ Bao, W. He, X. Huang, Y. Liu, R. Li, Z.
The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination
All age groups Human papillomavirus (HPV) Administration Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Langer, J. Welch, V. L. Moran, M. M. Cane, A. Lopez, S. M. C. Srivastava, A. Enstone, A. Sears, A. Markus, K. Heuser, M. Kewley, R. Whittle, I.
The Cost of Seasonal Influenza: A Systematic Literature Review on the Humanistic and Economic Burden of Influenza in Older (>= 65 Years Old) Adults
Older adults Influenza Economic aspects
Rating:
Not applicable
2024 ∙ Untung, T. Pandey, R. Johansson, P.
The cost-effectiveness of COVID-19 vaccination program among age-groups children, adults, and elderly in Europe: A systematic review
Europe All age groups COVID-19 Economic aspects
Rating:
Not applicable
Loading...